Discovery of Novel Dual Inhibitors of the Wild-Type and the Most Prevalent Drug-Resistant Mutant, S31N, of the M2 Proton Channel from Influenza A Virus-Reference-Cited by-同舟云学术

Discovery of Novel Dual Inhibitors of the Wild-Type and the Most Prevalent Drug-Resistant Mutant, S31N, of the M2 Proton Channel from Influenza A Virus

Published:2013-03-27 Issue:7 Volume:56 Page:2804-2812
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wang Jizhou¹,Ma Chunlong²,Wang Jun³,Jo Hyunil³,Canturk Belgin⁴,Fiorin Giacomo⁵,Pinto Lawrence H.²,Lamb Robert A.,Klein Michael L.⁵,DeGrado William F.³

Affiliation:

1. Influmedix Inc., 170 North Radnor-Chester Road, Suite 300, Radnor, Pennsylvania 19087, United States

2. Department of Molecular Biosciences, Northwestern University, Evanston, Illinois 60208, United States

3. Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States

4. Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104, United States

5. Institute for Computational Molecular Science and Department of Chemistry, Temple University, Philadelphia, Pennsylvania 19122-6078, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm301538e

Reference55 articles.

1. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

2. Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States

3. Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1)

4. Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008

5. Global Transmission of Oseltamivir-Resistant Influenza

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rimantadine derivatives with antiviral activity against flaviviruses and rimantadine-resistant strain of influenza A virus;Russian Chemical Bulletin;2024-06

2. Antiviral Compounds to Address Influenza Pandemics: An Update from 2016-2022;Current Medicinal Chemistry;2023-09-07

3. Virtual screening and molecular growth guide the design of inhibitors for the influenza virus drug-resistant mutant M2-V27A/S31N;Journal of Biomolecular Structure and Dynamics;2023-07-09

4. Aprotinin—Drug against Respiratory Diseases;International Journal of Molecular Sciences;2023-07-06

5. Amantadine variant – aryl conjugates that inhibit multiple M2 mutant – amantadine resistant influenza a viruses;European Journal of Medicinal Chemistry Reports;2022-12